Effect of phosphodiesterase inhibitors in the bladder

Many aging men will experience lower urinary tract symptoms (LUTS). Phosphodiesterase type 5 (PDE5) inhibitors have shown promise in treating LUTS in these patients. PDE5 inhibitors mediate their effects through several pathways including cAMP, NO/cGMP, K-channel modulated pathways, and the l-cystei...

Descripción completa

Detalles Bibliográficos
Autores principales: Chughtai, Bilal, Ali, Aizaz, Dunphy, Claire, Kaplan, Steven A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Second Military Medical University 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5730687/
https://www.ncbi.nlm.nih.gov/pubmed/29264117
http://dx.doi.org/10.1016/j.ajur.2015.04.014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5730687/
https://www.ncbi.nlm.nih.gov/pubmed/29264117
http://dx.doi.org/10.1016/j.ajur.2015.04.014

Ejemplares similares